Читать книгу Transition of Care - Группа авторов - Страница 42

1.During transition, it is important to understand that CAH is a lifelong disease that is genetically inherited.

2.The importance of a multidisciplinary follow-up throughout life and of treatment adherence should be emphasized.

3.The patient has to be able to self-manage treatment.

4.Regular monitoring of the efficacy of GC and MC replacement therapy, as well as periodic measurements and/or monitoring of weight, BMD, and CV risk factors should be carried out.

5.On a regular basis, gonadic function, sexuality, and fertility should be assessed.

6.Genetic counseling is warranted.

7.Psychological support is also necessary.